Growth Metrics

Tango Therapeutics (TNGX) Change in Acquisitions & Divestments (2020 - 2025)

Tango Therapeutics (TNGX) has 6 years of Change in Acquisitions & Divestments data on record, last reported at $39.5 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 53.35% year-over-year to $39.5 million; the TTM value through Dec 2025 reached $224.6 million, down 31.46%, while the annual FY2025 figure was $224.6 million, 31.46% down from the prior year.
  • Change in Acquisitions & Divestments reached $39.5 million in Q4 2025 per TNGX's latest filing, down from $66.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $109.3 million in Q1 2024 and bottomed at $30.4 million in Q3 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $67.0 million, with a median of $64.5 million recorded in 2022.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 106.98% in 2022, then crashed 53.35% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $59.9 million in 2021, then skyrocketed by 36.94% to $82.0 million in 2022, then increased by 3.79% to $85.1 million in 2023, then dropped by 0.43% to $84.7 million in 2024, then plummeted by 53.35% to $39.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $39.5 million in Q4 2025, $66.0 million in Q3 2025, and $41.3 million in Q2 2025.